• PP2A, Autophagy, and Candida Biofilm Resistance

  2026-08-25

  A 2025 study identifies PP2A catalytic subunit PPH21 as a regulator of Candida albicans biofilm formation and antifungal resistance through Atg13 phosphorylation and Atg1 activation. Its combination of genetic, pharmacological, cellular, and oral-infection models provides a mechanistic framework for studying how autophagy supports persistence during fungal infection research.

• Cy3 RNA Labeling Kit: Technical Workflow

  2026-08-24

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports T7 in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based research assays. It is intended for applications such as in situ hybridization and Northern blot hybridization, not diagnostic, therapeutic, or clinical use.

• SM-164: An Assay Framework for Apoptotic Signaling

  2026-08-23

  SM-164 is a bivalent Smac mimetic that provides a precise entry point for studying IAP-controlled apoptosis. This article connects its rapid cIAP degradation and TNFα-dependent apoptosis profile with new RNA Pol II degradation findings to improve assay interpretation without conflating distinct death triggers.

• Broad-Spectrum Bivalent mRNA Vaccine Against SARS-CoV-2

  2026-08-22

  Lu and colleagues evaluated RQ3025, a bivalent mRNA vaccine designed around conserved and recurrent spike mutations, in several animal models. The study found broad neutralizing activity, protection against emerging variants, a Th1-biased cellular response, and no evident organ pathology after high-dose administration, while also underscoring the limits of translating preclinical breadth into human protection.

• RBM3, MEF2C, and BBB Integrity in Alzheimer’s Disease

  2026-08-21

  The reference study identifies an RBM3–MEF2C regulatory axis that links Aβ-associated RNA destabilization to tight-junction loss and increased blood–brain barrier permeability. Its combination of RNA-binding, transcriptional, and barrier-function analyses provides a mechanistic framework for studying early neurovascular dysfunction in Alzheimer’s disease.

• Resiquimod (R-848): Assay Design for Tumor Ablation

  2026-08-20

  Resiquimod (R-848) is a dual TLR7/8 agonist that links innate immune response modulation with dendritic-cell and macrophage assays. This guide focuses on experimental design, causal controls, formulation variables, and translational interpretation in thermal-ablation research.

• Cy3 TSA Fluorescence System Kit for Liver Cancer

  2026-08-20

  Translate liver-cancer metabolism findings into sensitive protein and RNA imaging with the Cy3 TSA Fluorescence System Kit. Its HRP-driven deposition workflow supports spatial detection of SIX1, lipogenic enzymes, and regulatory transcripts when conventional fluorescence is too dim.

• PD 0332991: Translational Control of Cell-Cycle Biology

  2026-08-19

  A mechanistic and strategic guide to using PD 0332991 (Palbociclib HCl) to interrogate Rb-dependent cell-cycle control, while translating integrated genomic findings from pleural mesothelioma into biomarker-aware research hypotheses.

• BIBR 1532: Selective Telomerase Inhibitor Guide

  2026-08-19

  BIBR 1532 is a non-nucleosidic telomerase inhibitor that targets the hTERT reverse transcriptase component and is reported to inhibit telomerase with an IC50 of 93 nM. Its research applications include telomerase activity assay development, cancer cell proliferation inhibition, and apoptosis induction in leukemia cells.

• HyperScribe™ Poly (A) Tailing Kit for RNA

  2026-08-18

  Build more stable, translation-ready RNA for transfection experiments, micro-injection, and expression-rescue studies with a workflow designed around enzymatic polyadenylation. The kit also provides a practical way to test metabolic hypotheses inspired by recent TCAIM–OGDH research without confusing RNA engineering with direct mechanistic proof.

• CSBTA Pharmacokinetics in MASH: Study Insights

  2026-08-18

  This study integrates pharmacokinetic profiling, tissue distribution, transporter assays, and metabolic-enzyme analysis to explain how MASH alters exposure to key Corydalis saxicola Bunting total alkaloids. Its findings indicate that disease state and repeated dosing can increase systemic and hepatic exposure, providing a mechanistic basis for dose-regimen evaluation in MASLD/MASH research.

• 2'-O-Methyladenosine: Assay Workflows

  2026-08-17

  Use 2'-O-Methyladenosine as a defined chemical input for RNA modification studies, nucleoside transport experiments, and targeted purine metabolomics. This workflow-focused guide combines cell-based dosing with stable isotope-diluted UHPLC–MS/MS strategies to improve interpretation in complex biological matrices.

• Leucovorin Calcium in Patient-Derived Assembloids

  2026-08-17

  Leucovorin Calcium, also known as calcium folinate, can serve as a mechanistic rescue control for methotrexate studies while exposing how tumor–stroma interactions shape antifolate response. This article translates recent gastric cancer assembloid findings into a practical framework for assay design, resistance research, and patient-relevant model development.

• Hexetidine: From MIC to Oral Biofilm Models

  2026-08-16

  Hexetidine (NSC-17764) connects broad-spectrum oral antimicrobial activity with a practical framework for interpreting planktonic MIC, biofilm inhibition, and translational mouthwash data. This article explains how to build more defensible assays while separating product evidence from findings that require independent validation.

• LARP1, TOP mRNAs, and Repressed Ribosome Complexes

  2026-08-15

  Saba and colleagues show that LARP1 directly binds non-translating 40S ribosomal subunits through a previously uncharacterized domain that occludes the mRNA channel, while stress-associated 60S joining produces LARP1–80S complexes. The study separates ribosome binding from LARP1-dependent TOP-mRNA repression and stabilization, revising models in which ribosome association is assumed to be the primary cause of TOP regulation.

453 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page